The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or COPD alone. Patients wit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Expert Rev Clin Pharmacol
Autori principali: Louie, Samuel, Zeki, Amir A, Schivo, Michael, Chan, Andrew L, Yoneda, Ken Y, Avdalovic, Mark, Morrissey, Brian M, Albertson, Timothy E
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046086/
https://ncbi.nlm.nih.gov/pubmed/23473596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ecp.13.2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi